Notes
Slide Show
Outline
1
Epilepsy: Seizure mechanisms
  • Marc A. Dichter, M.D., Ph.D.


2
Epilepsy
  • Common - 1-2% of population
  • Chronic
  • Effects all ages
  • Expensive
  • Partially treatable
3
Definitions
  • Seizure = alteration in behavior associated with abnormal electrical activity of the brain
  • Epilepsy = condition in which an individual has recurrent, spontaneous, unprovoked seizures
4
Why do people develop seizures?
  • Many disturbances of brain physiology can produce seizures
    • Trauma
    • Ischemia
    • Infection
    • Electrolyte imbalances
    • Chemical imbalances
    • Toxins
    • Drugs or drug withdrawal
  • Many focal lesions may induce epilepsy
    • Tumors
    • Dysplasias
    • Gliotic scars
5
Seizures are a natural consequence of intrinsic brain anatomy and physiology
  • Any vertebrate brain can be induced to have a seizure with relatively little provocation
  • People can have seizures for minimal reasons - e.g. fainting, sleep deprivation
    • This is not epilepsy!
6
Three major questions:
  • How do seizures develop and then propagate so readily through the brain? --“ICTOGENESIS”
  • Why don’t we have seizures all the time?
  • How is brain structure/function altered after injury to produce hyperexcitability? -- “EPILEPTOGENESIS”
7
The epilepsies are a family of conditions and seizures can occur in many different varieties
  • Seizures need to be classified for diagnostic, prognostic and therapeutic reasons
  • Many different classification schemes based on phenomena, EEG, anatomical localization, etc.
  • Currrently accepted classification is based on seizure description and in some cases, EEG
8
Nomenclature
  • The seizure is the “ictus”
  • Time between seizures (when things seem to be “normal”) is the “interictal” period
  • We can then talk about “ictal” events and “interictal” events
9
Seizure types
  • Partial or focal seizures
  •    (assumes one or more focal areas of the cortex in which seizures originate)
    • Simple
    • Complex
    • With secondary generalization
10
Seizure types
  • Primary generalized seizures
  •    (assumes seizures start diffusely or in deep brain structures)
    • Absence (“Petit mal”)
    • Tonic clonic (“Grand mal”)
    • Tonic
    • Myoclonic
    • Atonic
11
Status epilepticus
  • Tonic clonic status
  • Absence status
  • Complex partial status
  • Epilepsia partialis continua
12
EEG
  • Records integrated synaptic currents from top 0.5 mm of cortex
  • Shows regular patterns during different wake and sleep stages
  • May be abnormal in individuals with epilepsy - abnormalities signify areas of hyperexcitability and hypersynchronous activation of cortex
  • EEG patterns change with age; epileptiform waves may disappear
13
The Electroencephalogram (EEG)
  • Recorded from scalp
  • Based on synaptic currents in underlying 0.5 mm of cortex
  • Coherent signals occur because of the columnar organization of the cortex
14
EEG patterns in epilepsy
  • Focal spike or sharp wave discharges
  • Focal slowing
  • Spike and wave discharges - may be diffuse and synchronous at ~ 3 Hz
  • Seizure discharges
15
 
16
Causes of epilepsy
  • Infection
  • Trauma
  • Status
  • Genetic
  • Idiopathic
17
Genetic epilepsies
  • Seen in mice and rats, as well as other species
  • Common in children (“idiopathic epilepsy”)
    • Most forms in human are not single gene inheritance
    • Many single gene mutations that cause epilepsy have now been identified and characterized
    • Often polygenic
18
Many single gene mutations in both mice and humans produce epilepsy syndromes
  • Many forms of absence epilepsy
    • mostly abnormal Ca channels
    • Na channels
    • GABAA receptors
  • Some partial epilepsies
  • Same phenotype can be produced by multiple gene abnormalities
  • One gene may produce several phenotypes
  • Some syndromes are age-related
  • Other genes may affect expression of the epilepsy gene
19
Evaluation of individuals with seizures
  • Look for acute illness (e.g. infection)
  • Look for chemical imbalance, toxin exposure
  • Look for anatomic lesion
  • Family history
20
 Critical issues in epilepsy research
  • What is the origin of the hyperexcitability?
  • How do seizures develop?
  • How do seizures spread through the brain?
  • How can the seizures be controlled?
  • How can epilepsy be prevented?
21
Mechanisms underlying seizures
  • Focal seizures
  • Generalized seizures
22
 
23
The Depolarizing Shift and Hyperpolarization
24
Role of GABA in Epilepsy
25
GABA-mediated inhibition
  • GABA (gamma-aminobutyric acid) is the main inhibitory neurotransmitter in forebrain
  • GABA acts on GABAA receptors to open Cl- channels and hyperpolarize the cell
  • Blocking GABA produces seizures
  • Enhancing GABA’s effects blocks seizures
  • GABAB receptors exist on axon terminals (presynaptic inhibition) and on postsynaptic cells
26
GABA Synapse
27
Spread of seizure activity to normal
areas of brain
  • Utilize normal synaptic pathways
  • Utilize normal synaptic mechanisms
  • Frequency-dependent events likely to be important
  • Local spread may involve non-synaptic mechanisms
28
How do seizures develop and spread
29
Epileptogenic zones
  • Within the damaged and regenerating regions, small islands of principle neurons develop in which recurrent excitatory feedback overwhelms recurrent inhibitory feedback, and in which gap junctions between axons may be enhanced
  • Within these small networks, groups of neurons fire repetitive highly synchronized bursts of action potentials
  • These can be recorded with field (EEG) electrodes as fast ripples
  • Under baseline conditions, these events remain confined to small regions and remain relatively infrequent
30
 
31
Localization of FR
32
 
33
Epileptogenic zones
  • FR and intracellular correlates resemble activity seen in acute chemically induced epileptic regions – e.g synchronous bursts of neurons
34
Epileptogenic zones
  • FR are generated by synchronous bursts of neurons


35
Ictogenesis
  • Regions of synchronized bursting increase in size and intensity as lateral inhibition breaks down
36
Ictogenesis
  • EEG shows increased energy, more frequent and larger very fast ripples, and other features, well before seizures begin (“the preictal cascade”).
37
Ictogenesis
  • This process becomes regenerative
    • Multiple excitatory synaptic events (utilizing AMPA, NMDA, and mGlu receptors)
    • Endogenous voltage-dependent currents (e.g. Ca)
    • Decreased feedback inhibition
    • Enhanced coupling
  • Increased neuronal excitability and synchrony
  • A seizure finally develops in a localized area and then spreads to nearby and distant regions
38
Ictogenesis
  • As overall excitability increases, the synchronized bursts increase in frequency
  • With each synchronized burst, extracellular K increases, and as the bursts increase in frequency, the Ko remains partially elevated
    • Increased Ko enhances axonal coupling and increases neuronal excitability
    • Increased Ko decreases “inhibitory” effects of opening K channels
39
 
40
Seizure development and spread
  • Afterdischarges lengthen and become more complex
  • Inhibition around the focus diminishes
  • ADs spread to nearby and distant areas of cortex
  • Areas of cortex with fast ripples may enlarge and coalesce
41
 
42
 
43
 
44
 
45
Primary Generalized Epilepsy
46
Primary generalized epilepsy
47
Role of bursting neurons in seizures
48
Primary generalized seizures
49
 
50
Activation of T currents by hyperpolarization
51
Post-inhibitory rebound spikes in thalamus
52
Genetic forms of epilepsy
  • Mouse models
    • Spontaneous epilepsy
    • Transgenic mice with specific gene knockouts
  • Human epilepsy syndromes
    • Single gene mutations
    • Susceptibility genes
53
Genetics of human epilepsies
  • Primary generalized syndromes
    • Benign familial neonatal convulsions – K channels (KCNQ2, KCNQ3)
    • Progressive myoclonic epilepsy – Unverricht-Lundborg – Cystatin B
    • Absence seizures – GABA(A) receptor subunits
  • Partial epilepsy syndromes
    • Autosomal dominant nocturnal frontal lobe epilepsy – Subunit of nicotinic acetylcholine receptor (CHRNA4 - alpha4 subunit)
    • Febrile seizures plus (FEBS+) - Subunits of Na channel
    • Several others recently identified
54
 Genetics of human epilepsies
  • Many syndromes known to be inherited
    • Childhood absence
    • Juvenile myoclonic epilepsy
    • Benign rolandic epilepsy with centrotemporal spikes
  • Some syndromes may be polygenic
  • Susceptibility and modifying genes may play large roles
55
Epilepsy treatment
  • Pharmacologic treatment
    • Block voltage dependent Na currents
    • Enhance GABA mediated inhibition
    • Block T currents
    • Other mechanisms (?)
  • Surgical treatment
    • Temporal lobectomy
    • Lesionectomies
    • Corpus callosotomy
56
Treatment must be matched to seizure type
  • Drugs for focal seizures may not work against absence seizures
  • Drugs for absence seizures may not work against focal seizures
  • Some drugs may make some seizure types worse
57
Mechanisms of actions of antiepileptic drugs
  • Block Na currents: voltage- and use-dependent
  • Enhance GABA-mediated IPSPs
    • Multiple specific mechanisms
      • Receptor specific
      • Receptor independent
  • Block T type Ca currents
  • Block kainate and enhance GABA
  • Bind to specific proteins – downstream mechanisms not yet known
    • Gabapentin – alpha 2 delta subunit of Ca channels
    • Levetiracetam – SV2A (synaptic vesicular protein)
58
Use dependent and voltage-dependent block of Na channels
59
 
60
Enhance GABA inhibition by other means
  • First group of “designer” drugs for epilepsy
  • Drugs block GABA uptake (Tiagabine) or block GABA metabolism (Vigabatrin - not available in US)
  • Not receptor-specific - Increasing GABA at synapses allows activation of all GABA receptors
  • Results are not always predictable
    • Different seizure types may be affected in opposite ways
61
GABA Synapse
62
Block T type Ca currents
63
How are new antiepileptic drugs developed?
  • Screen against seizure (not epilepsy) models in mice and rats
  • Target-specific molecular mechanisms
    • NMDA receptor antagonists
    • AMPA receptor antagonists
    • GABA agonists
    • Adenosine agonists
    • K channel activators
    • Binding sites identified by other drugs